cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Revance Therapeutics Inc
5 own
8 watching
Current Price
$0
$0.21
(0.6%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,902.26M
52-Week High
52-Week High
35.99
52-Week Low
52-Week Low
11.27
Average Volume
Average Volume
0.11M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,902.26M
icon52-Week High35.99
icon52-Week Low11.27
iconAverage Volume0.11M
iconDividend Yield--
iconP/E Ratio--
What does the Revance Therapeutics Inc do?
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark, California.
Read More
How much money does Revance Therapeutics Inc make?
News & Events about Revance Therapeutics Inc.
Business Wire
2 months ago
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the 34th Annual Piper Sandler Healthcare Conference, taking place November 29-December 1, 2022, in New York City. Chief...
PR Newswire
2 months ago
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID PR Newswire PALM BEACH, Fla., Nov. 17, 2022 FinancialNewsMedia.com News Commentary - Since the beginning of the pandemic...
Business Wire
2 months ago
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the Stifel 2022 Healthcare Conference, taking place November 15-16, 2022, in New York City. Chief Financial Officer...
Business Wire
3 months ago
Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial-stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the publication of two peer-reviewed articles in the Aesthetic Surgery Journal, the official journal of The Aesthetic Society. The...
Business Wire
3 months ago
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, announced today it will present two video abstracts featuring DAXXIFY (DaxibotulinumtoxinA-lanm) for injection at the American Society for Dermatologic Surgery (ASDS) Annual...
Frequently Asked Questions
Frequently Asked Questions
What is Revance Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Revance Therapeutics Inc shares?
plus_minus_icon
How can I buy Revance Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Revance Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Revance Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Revance Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Revance Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Revance Therapeutics Inc?
plus_minus_icon
What percentage is Revance Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Revance Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.21
(0.6%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00